Depression and Breast Cancer in Morocco: Prevalence and Associated Factors
Background. Depression is frequently associated with breast cancer. However, its prevalence and impact on patients’ quality of life are negligible. Depression is often underdiagnosed and less treated. Objectives. Our study is aimed at estimating the prevalence of depression in breast cancer patients...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.1155/2023/3277929 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849467928278204416 |
|---|---|
| author | Khadija Benallel Rajae El Kilali Roukaya Benjelloun Mohamed Kadiri |
| author_facet | Khadija Benallel Rajae El Kilali Roukaya Benjelloun Mohamed Kadiri |
| author_sort | Khadija Benallel |
| collection | DOAJ |
| description | Background. Depression is frequently associated with breast cancer. However, its prevalence and impact on patients’ quality of life are negligible. Depression is often underdiagnosed and less treated. Objectives. Our study is aimed at estimating the prevalence of depression in breast cancer patients, describing their sociodemographic and clinical profile, and determining the factors associated with this depression. Material and Methods. We carried out a cross-sectional, descriptive, and analytical study, conducted from January to March 2018 at Mohammed V Military Hospital in Rabat. The survey included 100 breast cancer patients. It was conducted using an anonymous questionnaire, the Mini International Neuropsychiatric Interview test (MINI test) to diagnose depression and the Beck Depression Inventory (BDI) to assess its severity. Results. The major depressive episode was diagnosed in 26% of breast cancer patients. Age under 40, psychiatric history, metastatic breast cancer, refusal of treatment, heavier treatment, and spousal alteration were the factors most associated with higher depression prevalence in these patients. Discussion and Conclusion. The high prevalence of depression in breast cancer patients, as well as the influence of personal characteristics and treatment in the occurrence of this ailment, has been confirmed by several authors. It is recommended to improve the psychooncological care of patients with breast cancer, to prevent the occurrence of depression in this vulnerable population. |
| format | Article |
| id | doaj-art-e135eba99ad34551be12c0dea6640d97 |
| institution | Kabale University |
| issn | 2090-3189 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Breast Cancer |
| spelling | doaj-art-e135eba99ad34551be12c0dea6640d972025-08-20T03:25:59ZengWileyInternational Journal of Breast Cancer2090-31892023-01-01202310.1155/2023/3277929Depression and Breast Cancer in Morocco: Prevalence and Associated FactorsKhadija Benallel0Rajae El Kilali1Roukaya Benjelloun2Mohamed Kadiri3Psychiatry DepartmentIbn Sina University Hospital of RabatPsychiatry DepartmentPsychiatry DepartmentBackground. Depression is frequently associated with breast cancer. However, its prevalence and impact on patients’ quality of life are negligible. Depression is often underdiagnosed and less treated. Objectives. Our study is aimed at estimating the prevalence of depression in breast cancer patients, describing their sociodemographic and clinical profile, and determining the factors associated with this depression. Material and Methods. We carried out a cross-sectional, descriptive, and analytical study, conducted from January to March 2018 at Mohammed V Military Hospital in Rabat. The survey included 100 breast cancer patients. It was conducted using an anonymous questionnaire, the Mini International Neuropsychiatric Interview test (MINI test) to diagnose depression and the Beck Depression Inventory (BDI) to assess its severity. Results. The major depressive episode was diagnosed in 26% of breast cancer patients. Age under 40, psychiatric history, metastatic breast cancer, refusal of treatment, heavier treatment, and spousal alteration were the factors most associated with higher depression prevalence in these patients. Discussion and Conclusion. The high prevalence of depression in breast cancer patients, as well as the influence of personal characteristics and treatment in the occurrence of this ailment, has been confirmed by several authors. It is recommended to improve the psychooncological care of patients with breast cancer, to prevent the occurrence of depression in this vulnerable population.http://dx.doi.org/10.1155/2023/3277929 |
| spellingShingle | Khadija Benallel Rajae El Kilali Roukaya Benjelloun Mohamed Kadiri Depression and Breast Cancer in Morocco: Prevalence and Associated Factors International Journal of Breast Cancer |
| title | Depression and Breast Cancer in Morocco: Prevalence and Associated Factors |
| title_full | Depression and Breast Cancer in Morocco: Prevalence and Associated Factors |
| title_fullStr | Depression and Breast Cancer in Morocco: Prevalence and Associated Factors |
| title_full_unstemmed | Depression and Breast Cancer in Morocco: Prevalence and Associated Factors |
| title_short | Depression and Breast Cancer in Morocco: Prevalence and Associated Factors |
| title_sort | depression and breast cancer in morocco prevalence and associated factors |
| url | http://dx.doi.org/10.1155/2023/3277929 |
| work_keys_str_mv | AT khadijabenallel depressionandbreastcancerinmoroccoprevalenceandassociatedfactors AT rajaeelkilali depressionandbreastcancerinmoroccoprevalenceandassociatedfactors AT roukayabenjelloun depressionandbreastcancerinmoroccoprevalenceandassociatedfactors AT mohamedkadiri depressionandbreastcancerinmoroccoprevalenceandassociatedfactors |